Reem AlQarni

Dr. Reem AlQarni


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AAABDULRHMAN AL ABDULQADER
ABDULRHMAN AL ABDULQADER
JAJawad S. Alnajjar
Jawad S. Alnajjar
LALama Zaid Alzimami
Lama Zaid Alzimami
RAReem AlQarni
Reem AlQarni
FMFathima Raahima Riyas Mohamed
Fathima Raahima Riyas Mohamed
AAAhmed Albadrani
Ahmed Albadrani
Background/Objectives: Azathioprine (AZA) is widely used for maintaining remission in inflammatory bowel disease (IBD), but the implications of its withdrawal remain unclear. This study evaluates relapse rates after AZA discontinuation in adult IBD patients in remission and identifies predictors of relapse. Methods: A systematic review and meta-analysis were conducted according to PRISMA 2020 guidelines and registered in PROSPERO (CRD420251016594). Databases were searched from inception to 4 January 2025, including RCTs and cohort studies involving adult IBD patients who discontinued AZA in clinical remission. The main outcome assessed was relapse incidence, with additional outcomes covering time until relapse, predictors of relapse, and management following relapse. Random-effects meta-analysis, subgroup analyses, and meta-regression were performed. Results: Twenty-two studies comprising 3057 patients were included. The pooled relapse rate after AZA withdrawal was 32.5% (95% CI: 28.2–37.2%; I2 = 94.2%). UC patients exhibited higher relapse rates (41.3%) than CD patients (24.7%, p = 0.003). Shorter AZA duration, elevated CRP, and absence of mucosal healing were associated with increased relapse risk. Meta-regression identified AZA duration as a significant predictor (β = −0.18, p = 0.009). Post-relapse management often involved AZA reintroduction or escalation to biologics, with low surgery rates. The GRADE assessment revealed that the certainty of evidence for the majority of primary outcomes was classified as low to very low. Conclusions: While this meta-analysis suggests that relapse after AZA withdrawal occurs frequently in IBD patients, the low to very low certainty of evidence limits definitive recommendations. The significant heterogeneity indicates that relapse risk varies across different patient populations and different settings.

13 September 2024 in Cureus
Verified
Journal Article
Open access
PDF file
RAReem AlQarni
Reem AlQarni
HAHawra M. Aldandan
Hawra M. Aldandan
ZAZainab Ali Alnahwi
Zainab Ali Alnahwi
DADhiyaa A. Almusaylim
Dhiyaa A. Almusaylim
RARana AlQarni
Rana AlQarni
HIHawra M. Aldandan Ii
Hawra M. Aldandan Ii
Background Osteoarthritis (OA), common in older adults, leads to joint degradation and inflammation, with risk factors including age, obesity, and genetics. OA strongly indicates cardiovascular disease (CVD), with shared risk factors such as lack of exercise and muscle weakness. This study explores the awareness of OA and its relationship to CVD risk factors. Methodology This cross-sectional study in Al Ahsa, Saudi Arabia, involved an online self-administered questionnaire distributed via Google Forms to randomly selected adults, with ages ranging from 18 to 65 years. Informed consent was taken from all participants. Data was cleaned in Excel and analyzed using SPSS version 29 (IBM Corp., Armonk, NY, USA). Results Our study assessed the awareness of 381 participants about the relationship between OA and CVD. Most participants were female 312 (81.9%). Overall, 250 (65.6%) participants were aged 18-27, and 362 (95.0%) were Saudi nationals. Further, 210 (55.1%) participants had a bachelor’s degree, and 223 (58.5%) were students. Healthcare exposure varied, with 207 (54.3%) having no background, and 157 (41.2%) being healthcare students. Notably, 152 (39.9%) knew someone diagnosed with OA, of whom 55 (14.4%) also had CVD. Significant predictors of awareness included studying in healthcare (Exp(B) = 3.325, p = 0.001), receiving OA information (Exp(B) = 2.222, p = 0.007), sources such as school/university (Exp(B) = 7.851, p = 0.000), and personal experience (Exp(B) = 4.768, p = 0.034). Conclusions This study showed a notable gap in awareness about the link between OA and CVD in Al Ahsa, Saudi Arabia. While those with healthcare exposure showed good knowledge, many lacked an understanding of their relationship. Targeted education, particularly for younger and non-healthcare-educated groups, is crucial for improving awareness and promoting effective lifestyle modifications to manage both OA and CVD risks.